Changes in hypothalamic paraventricular nucleus catecholaminergic activity after acute and chronic morphine administration

European Journal of Pharmacology

Volumn 388, Issue 1, 2000, Pages 49-56

  Fuertes, Gregorio ^a   Milanés, M Victoria ^a   Rodríguez Gago, Manuel ^b   Marín, M Teresa ^c   Laorden, M Luisa ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c Facultad de Farmacia   (Spain)

Author keywords

Dopamine; Hypothalamus pituitary adrenocortical axis; Morphine; Noradrenaline; Paraventricular nucleus; Tolerance

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CORTICOSTERONE; CYCLIC AMP; DOPAMINE; MORPHINE; NORADRENALIN;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC SYSTEM; DRUG TOLERANCE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; CATECHOLAMINES; CORTICOSTERONE; CYCLIC AMP; DOPAMINE; DRUG TOLERANCE; MALE; METHOXYHYDROXYPHENYLGLYCOL; MORPHINE; NARCOTICS; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0033971408     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00829-8     Document Type: Article

References (35)

1. Alcaraz C., Vargas M.L., Fuente T., Milanés M.V. Chronic naloxone treatment induced supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level. J. Pharmacol. Exp. Ther. 266:1993;1602-1606.
2. Artigas F., Sarrias M.J., Adell A., Gelpí E. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sci. 39:1986;1571-1578.
3. Berhow M.T., Russel D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience. 68:1995;969-979.
4. Borowsky B., Kuhn C.M. GBR12909 stimulates hypothalamo-pituitary-adrenal activity by inhibition of uptake at hypothalamic dopaminergic neurons. Brain Res. 613:1993;251-258.
5. Buckingham J.C., Cooper T.A. Differences in hypothalamic-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology. 38:1984;411-417.
6. Cunningham E.T., Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274:1988;60-76.
7. Emanuel R.L., Girard D.M., Thull D.L., Majzoub J.A. Second messengers involved in the regulation of corticotrophin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology. 126:1990;3016-3021.
8. Everitt B.J., Meister B., Hökfelt T. The organization of monoaminergic neurons in the hypothalamus in relation to neuroendocrine integration. Nemeroff C.B. Neuroendocrinology. 1992;87-127 CRC Press, Boca Raton.
9. Gonzálvez M.L., Milanés M.V., Martínez-Piñero M.G., Marín M.T., Vargas M.L. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naïve rats and after naloxone-induced withdrawal. Brain Res. 647:1994;199-203.
10. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the tar locus coeruleus. J. Neurochem. 58:1992;1168-1171.
11. Ignar D.M., Kuhn C.M. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J. Pharmacol. Exp. Ther. 255:1990;1287-1295.
12. Itoi K., Horiba N., Tozawa F., Sakai Y., Sakai K., Demura H., Suda T. Major role of 3′,5′-cyclic adenosine monophosphate-dependent protein kinase A pathways in corticotrophin-releasing factor gene expression in the rat hypothalamus in vivo. Endocrinology. 137:1996;2389-2396.
13. Itoi K., Suda T., Tozawa F., Dobashi I., Ohmori N., Sakai Y., Abe K., Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology. 135:1994;2177-2182.
14. Lookingland K.J., Ireland L.M., Gunnet J.W., Manzanares J., Tian Y., Moore K.E. 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons. Brain Res. 559:1991;82-88.
15. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
16. Manzanares J., Lookingland K.J., Moore K.E. Kappa-opioid receptor-mediated regulation of α-melanocyte stimulating hormone secretion and tuberohypophysial dopaminergic neuronal activity. Neuroendocrinology. 52:1990;200-205.
17. Martínez J.A., Vargas M.L., Fuente T., del Río-García J., Milanés M.V. Plasma β-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal. Eur. J. Pharmacol. 182:1990;117-123.
18. Martínez-Piñero M.G., Milanés M.V., Alcaraz C., Vargas M.L. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of α- and β-adrenoceptors. Brain Res. 668:1994;122-128.
19. Milanés M.V., Laorden M.L., Chapleur-Chateau M., Burlet A. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;603-610.
20. Nestler E.J. Molecular mechanism of drug addiction. J. Neurosci. 12:1992;2439-2450.
21. Nestler E.J., Hope B.T., Widnell K.L. Drug addiction: a model for molecular basis of neural plasticity. Neuron. 11:1993;995-1006.
22. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin releasing factor. Pharmacol. Rev. 43:1991;425-473.
23. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59:1973;449-450.
24. Palkovits M. Anatomy of neural pathways affecting CRH secretion. Ann. N. Y. Acad. Sci. 512:1987;139-148.
25. Palkovits M., Brownstein M.J. Maps and Guide to Microdissection of the Rat Brain. 1988;Elsevier, New York, NY.
26. Petrusz P., Merchenthaler I. The corticotropin-releasing factor system. Nemeroff C.B. Neuroendocrinology. 1992;129-183 CRC Press, Boca Raton.
27. Plotsky P.M., Cunningham E.T., Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotrophin secretion. Endocr. Rev. 10:1989;437-458.
28. Suemaru S., Dallman M.F., Darlington D.N., Cascio C.S., Shisako J. Role of alpha adrenergic mechanisms in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat. Neuroendocrinology. 49:1989;181-190.
29. Szafarczyk A., Malaval F., Laurent A., Gibaud R., Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotrophin release in the rat. Endocrinology. 121:1987;883-892.
30. Torres G., Horowitz J.M. Individual and combined effects of ethanol and cocaine on intracellular signals and gene expression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 20:1996;561-596.
31. Torres G., Horowitz J.M., Lee S., Rivier C. Cocaethylene stimulates the secretion of ACTH and corticosterone and the transcriptional activation of hypothalamic NGFI-B. Mol. Brain Res. 43:1996;225-232.
32. Valverde O., Tzavara E., Hanoune J., Roques B.P., Maldonado R. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal. Eur. J. Neurosci. 8:1997;2671-2678.
33. Wang X.Q., Imaki T., Shibasaki T., Yamauchi N., Demura H. Intracerebroventricular administration of β-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat. Brain Res. 707:1996;189-195.
34. Widmaier E.P., Lim A., Vale W. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. Endocrinology. 124:1989;583-590.
35. Yokoe T., Audhya T., Brown C., Hutchinson B., Passarelli J., Hollander C.S. Corticotropin-releasing factor levels in the peripheral plasma and hypothalamus of the rat vary in parallel with changes in the pituitary-adrenal axis. Endocrinology. 123:1988;1348-1354.